(Q43557094)

24 November 2017

title

Latent hematopoietic stem cell toxicity associated with protracted drug administration (English)

1 reference

24 November 2017

2

1 reference

24 November 2017

3

1 reference

24 November 2017

K A Keyes

1

1 reference

24 November 2017

R E Parchment

series ordinal

4

1 reference

24 November 2017

B Albella

series ordinal

5

1 reference

24 November 2017

publication date

1 March 2001

1 reference

24 November 2017

published in

Experimental Hematology

1 reference

24 November 2017

volume

29

1 reference

24 November 2017

issue

3

1 reference

24 November 2017

page(s)

286-294

1 reference

Phase I trial of low-dose continuous topotecan infusion in patients with cancer: an active and well-tolerated regimen

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2800%2900670-6

7 January 2021

A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program Study

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2800%2900670-6

7 January 2021

Schedule dependence of sensitivity to 2',2'-difluorodeoxycytidine (Gemcitabine) in relation to accumulation and retention of its triphosphate in solid tumour cell lines and solid tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2800%2900670-6

7 January 2021

Antitumor activity of prolonged as compared with bolus administration of 2',2'-difluorodeoxycytidine in vivo against murine colon tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2800%2900670-6

7 January 2021

Assessing permanent damage to primitive hematopoietic stem cells after chemotherapy using the competitive repopulation assay

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2800%2900670-6

7 January 2021

The growth of mouse bone marrow cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2800%2900670-6

7 January 2021

Increasing dose intensity of cisplatin-etoposide in advanced nonsmall cell lung carcinoma: a phase III randomized trial of the Spanish Lung Cancer Group

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2800%2900670-6

7 January 2021

10.1016/S0301-472X(00)00670-6

Identifiers

DOI

1 reference

24 November 2017

1 reference